Pharmatek Laboratories, Inc. has acquired the Xcelodose 600S system, adding to its preclinical and early phase clinical GMP supply capabilities. The company will install the unit in its solid dose manufacturing facility in San Diego, CA and it’s expected to be validated by mid-October. The company is currently scheduling Xcelodose manufacturing productions for November and December. “Pharmatek is always looking for ways to move our customers’ drug candidates into the clinic more e...